China Life Insurance (NYSE:LFC) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Monday. The brokerage presently has a $16.00 price target on the financial services provider’s stock. Zacks Investment Research‘s price target would indicate a potential upside of 15.52% from the stock’s previous close.
According to Zacks, “China Life’s net profit owing to equity holders was $5.1 billion (RMB 32.2 billion) at 2017-end, reflecting 68.6% year-over-year growth on higher revenues. The company’s robust market position and organic growth initiatives also encourage. Its operational efficiency is further reflected in product upgrades and premium growth over the past many quarters. Its solid investment management continues to impress. The company has the most extensive distribution and service network among its peers operating in China. However, rising expenses continue to hurt its bottom line. Moreover, the downturn in the Chinese economy and economic volatility outside China continues to hurt its operation. Although shares of the company have underperformed the industry in a year's time, its strong fundamentals are likely to favor the stock going forward.”
LFC has been the topic of several other research reports. Credit Suisse Group cut China Life Insurance from a “neutral” rating to an “underperform” rating in a report on Thursday, January 4th. Goldman Sachs cut China Life Insurance from a “buy” rating to a “neutral” rating in a report on Wednesday, December 13th. Sanford C. Bernstein raised China Life Insurance from a “market perform” rating to an “outperform” rating in a report on Monday, January 8th. Deutsche Bank cut China Life Insurance from a “buy” rating to a “hold” rating in a report on Thursday, January 4th. Finally, UBS raised China Life Insurance from a “neutral” rating to a “buy” rating in a report on Tuesday, December 5th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $16.00.
Large investors have recently made changes to their positions in the business. Comgest Global Investors S.A.S. raised its stake in China Life Insurance by 7.9% during the 4th quarter. Comgest Global Investors S.A.S. now owns 124,355 shares of the financial services provider’s stock valued at $1,941,000 after purchasing an additional 9,100 shares during the period. Aperio Group LLC raised its stake in China Life Insurance by 9.8% during the 4th quarter. Aperio Group LLC now owns 584,982 shares of the financial services provider’s stock valued at $9,132,000 after purchasing an additional 52,023 shares during the period. Arrowstreet Capital Limited Partnership raised its stake in China Life Insurance by 26.4% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,381,719 shares of the financial services provider’s stock valued at $21,569,000 after purchasing an additional 288,279 shares during the period. US Bancorp DE raised its stake in China Life Insurance by 28.2% during the 4th quarter. US Bancorp DE now owns 55,364 shares of the financial services provider’s stock valued at $865,000 after purchasing an additional 12,171 shares during the period. Finally, Bain Capital Public Equity Management LLC acquired a new stake in China Life Insurance during the 4th quarter valued at $11,203,000. 0.40% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION NOTICE: This story was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.tickerreport.com/banking-finance/3302109/china-life-insurance-lfc-raised-to-buy-at-zacks-investment-research.html.
China Life Insurance Company Profile
China Life Insurance Company Limited is a life insurance company. The Company provides a range of insurance products, including individual and group life insurance, health insurance and accident insurance products. It operates through three segments: Life Insurance, Health Insurance, and Accident Insurance.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for China Life Insurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Life Insurance and related companies with MarketBeat.com's FREE daily email newsletter.